Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:administeredBy |
gptkb:Kazakhstan
gptkb:Russia gptkb:Uzbekistan |
| gptkbp:antigen |
inactivated SARS-CoV-2 virus
|
| gptkbp:ATCCode |
gptkb:J07BX03
|
| gptkbp:clinicalTrialPhase |
Phase III (as of 2021)
|
| gptkbp:countryOfOrigin |
gptkb:Russia
|
| gptkbp:dateOfAuthorization |
2021-02-20
|
| gptkbp:developedBy |
gptkb:Chumakov_Centre
|
| gptkbp:developerType |
gptkb:research_institute
|
| gptkbp:doseInterval |
14 days
|
| gptkbp:emergencyServices |
gptkb:Russia
|
| https://www.w3.org/2000/01/rdf-schema#label |
CoviVac
|
| gptkbp:manufacturer |
gptkb:Chumakov_Centre
|
| gptkbp:numberOfDoses |
2
|
| gptkbp:relatedTo |
gptkb:COVID-19_pandemic
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:storage |
+2 to +8°C
|
| gptkbp:target |
gptkb:COVID-19
|
| gptkbp:type |
inactivated virus vaccine
|
| gptkbp:bfsParent |
gptkb:Novavax
|
| gptkbp:bfsLayer |
6
|